Ravi Singh
Senior Scientist Sutro Biopharma
Ravi Singh, PhD, is a Senior Scientist at Sutro Biopharma, where he contributes to the design and optimization of next‑generation ADC linker‑payloads and leads medicinal chemistry efforts enabled by Sutro’s cell‑free XpressCF+® platform. He previously served as a Scientist in Medicinal Chemistry at Sutro and spent several years at Nanosyn advancing small‑molecule discovery programs. Before joining industry in the U.S., Ravi held multiple research and senior research roles at TCG Lifesciences, driving synthetic chemistry and lead‑optimization campaigns. He earned his PhD in Natural Product Total Synthesis from The University of Texas at Arlington and brings deep expertise in complex molecule construction and medicinal chemistry innovation.
Seminars
- Understanding PEGylated bidentate β-glucuronidase–cleavable linker design
- Enabling stable site-specific ADCs at DAR 16 to achieve higher efficacy
- Highlighting PEGylation mitigation of hydrophobicity and aggregation to improve pharmacokinetics and enhance in vivo antitumor efficacy
